U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Wilt TJ, MacDonald R, Ouellette J, et al. Treatment for Restless Legs Syndrome [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. (Comparative Effectiveness Reviews, No. 86.)

Cover of Treatment for Restless Legs Syndrome

Treatment for Restless Legs Syndrome [Internet].

Show details

Appendix HAppendix References

1.
Bassetti CL, Bornatico F, Fuhr P, et al. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial. Swiss Medical Weekly. 2011;141:w13274. [PubMed: 22101745]
2.
Benes H, Mattern W, Peglau I, et al. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study. Journal of Neurology. 2011 Jun;258(6):1046–54. [PubMed: 21188406]
3.
Hogl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Medicine. 2011 Apr;12(4):351–60. [PubMed: 21354368]
4.
Montagna P, Hornyak M, Ulfberg J, et al. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood. Sleep Medicine. 2011 Jan;12(1):34–40. [PubMed: 20965780]
5.
Hening WA, Allen RP, Ondo WG, et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Movement Disorders. 2010 Aug 15;25(11):1675–83. [PubMed: 20629075]
6.
Oertel W, Trenkwalder C, Benes H, et al. Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. Lancet Neurology. 2011 Aug;10(8):710–20. [PubMed: 21705273]
7.
Ferini-Strambi L, Aarskog D, Partinen M, et al. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Medicine. 2008 Dec;9(8):874–81. [PubMed: 18952497]
8.
Kushida CA, Geyer J, Tolson JM, et al. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome. Clinical Neuropharmacology. 2008 Sep–Oct;31(5):281–6. [PubMed: 18836346]
9.
Oertel WH, Benes H, Garcia-Borreguero D, et al. Efficacy of rotigotine transdermal system in severe restless legs syndrome: a randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe. Sleep Medicine. 2008 Mar;9(3):228–39. [PubMed: 17553743]
10.
Trenkwalder C, Benes H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurology. 2008 Jul;7(7):595–604. [PubMed: 18515185]
11.
Oertel WH, Stiasny-Kolster K, Bergtholdt B, et al. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Movement Disorders. 2007 Jan 15;22(2):213–9. [PubMed: 17133582]
12.
Adler CH, Hauser RA, Sethi K, et al. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology. 2004 Apr 27;62(8):1405–7. [PubMed: 15111683]
13.
Bogan RK, Fry JM, Schmidt MH, et al. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clinic Proceedings. 2006 Jan;81(1):17–27. [PubMed: 16438474]
14.
Montplaisir J, Karrasch J, Haan J, et al. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Movement Disorders. 2006 Oct;21(10):1627–35. [PubMed: 16874755]
15.
Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006 Sep 26;67(6):1034–9. [PubMed: 16931507]
16.
Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Jan;75(1):92–7. [PMC free article: PMC1757460] [PubMed: 14707315]
17.
Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Movement Disorders. 2004 Dec;19(12):1414–23. [PubMed: 15390050]
18.
Lee DO, Ziman RB, Perkins AT, et al. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. Journal of Clinical Sleep Medicine. 2011 Jun 15;7(3):282–92. [PMC free article: PMC3113968] [PubMed: 21677899]
19.
Winkelman JW, Bogan RK, Schmidt MH, et al. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Movement Disorders. 2011 Sep;26(11):2065–72. [PubMed: 21611981]
20.
Allen R, Chen C, Soaita A, et al. A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Sleep Medicine. 2010 Jun;11(6):512–9. [PubMed: 20466589]
21.
Bogan RK, Bornemann MAC, Kushida CA, et al. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clinic Proceedings. 2010 Jun;85(6):512–21. [Erratum appears in Mayo Clin Proc. 2010 Jul;85(7):693–4] [PMC free article: PMC2878254] [PubMed: 20511481]
22.
Garcia-Borreguero D, Larrosa O, Williams AM, et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology. 2010 Jun 8;74(23):1897–904. [PubMed: 20427750]
23.
Kushida CA, Becker PM, Ellenbogen AL, et al. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology. 2009 Feb 3;72(5):439–46. [PubMed: 19188575]
24.
Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002 Nov 26;59(10):1573–9. [PubMed: 12451200]
25.
Bayard M, Bailey B, Acharya D, et al. Bupropion and restless legs syndrome: a randomized controlled trial. Journal of the American Board of Family Medicine: JABFM. 2011 Jul–Aug;24(4):422–8. [PubMed: 21737767]
26.
Allen RP, Adler CH, Du W, et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Sleep Medicine. 2011 Oct;12(9):906–13. [PubMed: 21978726]
27.
Trenkwalder C, Benes H, Grote L, et al. Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial. Movement Disorders. 2007 Apr 15;22(5):696–703. [PubMed: 17274039]
28.
Oertel WH, Benes H, Bodenschatz R, et al. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR). Neurology. 2006 Sep 26;67(6):1040–6. [PubMed: 16931508]
29.
Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology. 2004 Dec 28;63(12):2272–9. [Summary for patients in Neurology. 2004 Dec 28;63(12):E21–2. PMID: 15623673] [PubMed: 15623686]
30.
Grote L, Leissner L, Hedner J, et al. A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Movement Disorders. 2009 Jul 30;24(10):1445–52. [PubMed: 19489063]
31.
Wang J, O'Reilly B, Venkataraman R, et al. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. Sleep Medicine. 2009 Oct;10(9):973–5. [PubMed: 19230757]
32.
Cuellar NG, Ratcliffe SJ. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome? Alternative Therapies in Health & Medicine. 2009 Mar–Apr;15(2):22–8. [PubMed: 19284179]
33.
Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest. 2009 Jan;135(1):74–80. [PubMed: 19017878]
34.
Aukerman MM, Aukerman D, Bayard M, et al. Exercise and restless legs syndrome: a randomized controlled trial. Journal of the American Board of Family Medicine: JABFM. 2006 Sep–Oct;19(5):487–93. [PubMed: 16951298]
35.
Oertel WH, Benes H, Garcia-Borreguero D, et al. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study. Sleep Medicine. 2010 Oct;11(9):848–56. [PubMed: 20813583]
36.
Mitchell UH, Myrer JW, Johnson AW, et al. Restless legs syndrome and near-infrared light: An alternative treatment option. Physiotherapy Theory & Practice. 2011 Jul;27(5):345–51. [PubMed: 20977377]
37.
Cuellar NG, Strumpf NE, Ratcliffe SJ. Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life. Journal of the American Geriatrics Society. 2007 Sep;55(9):1387–92. [PubMed: 17915343]
38.
Allen RP, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Movement Disorders. 2011 Jan;26(1):114–20. [PubMed: 21322022]
39.
Ellenbogen AL, Thein SG, Winslow DH, et al. A 52-week study of gabapentin enacarbil in restless legs syndrome. Clinical Neuropharmacology. 2011 Jan–Feb;34(1):8–16. [PubMed: 21242741]
40.
Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Movement Disorders. 2001 Nov;16(6):1105–9. [PubMed: 11748742]
41.
Silver N, Allen RP, Senerth J, et al. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome. Sleep Medicine. 2011 May;12(5):440–4. [PubMed: 21239226]
42.
Trenkwalder C, Collado Seidel V, Kazenwadel J, et al. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome? Movement Disorders. 2003 Oct;18(10):1184–9. [PubMed: 14534925]
43.
Inoue Y, Kuroda K, Hirata K, et al. Long-term open-label study of pramipexole in patients with primary restless legs syndrome. Journal of the Neurological Sciences. 2010 Jul 15;294(1–2):62–6. [PubMed: 20451927]
44.
Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep. 2003 Nov 1;26(7):819–21. [PubMed: 14655914]
45.
Montplaisir J, Fantini ML, Desautels A, et al. Long-term treatment with pramipexole in restless legs syndrome. European Journal of Neurology. 2006 Dec;13(12):1306–11. [PubMed: 17116213]
46.
Garcia-Borreguero D, Grunstein R, Sridhar G, et al. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Sleep Medicine. 2007 Nov;8(7–8):742–52. [PubMed: 17512789]
47.
Ondo W, Romanyshyn J, Vuong KD, et al. Long-term treatment of restless legs syndrome with dopamine agonists. Archives of Neurology. 2004 Sep;61(9):1393–7. [PubMed: 15364685]
Copyright Notice
Bookshelf ID: NBK115374
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.6M)

Other titles in these collections

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...